Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
1985-9-26
|
pubmed:abstractText |
Lidocaine hydrochloride is commonly infused intravenously to prevent ventricular arrhythmias. In some patients, elevations in serum lidocaine levels can cause serious toxic effects. In a group of 19 patients given a constant infusion of lidocaine, we confirmed the observation that serum lidocaine levels rose significantly between four and 24 hours after initiation of therapy. One of these patients manifested a toxic reaction to lidocaine. The lidocaine infusion rate was modified in a second group of 32 patients on the basis of the four-hour serum level. In these patients, after dosage adjustment, the mean lidocaine level did not rise, and all levels remained within the 2- to 4-mg/L therapeutic range at 24 hours. Without dosage adjustment, half of these levels would have fallen outside the desired range. A simple formula can be used to adjust prophylactic lidocaine infusion rates to attain levels that remain therapeutic, yet nontoxic.
|
pubmed:grant | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0003-9926
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1588-91
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:4026487-Adult,
pubmed-meshheading:4026487-Aged,
pubmed-meshheading:4026487-Arrhythmias, Cardiac,
pubmed-meshheading:4026487-Drug Administration Schedule,
pubmed-meshheading:4026487-Female,
pubmed-meshheading:4026487-Humans,
pubmed-meshheading:4026487-Infusions, Parenteral,
pubmed-meshheading:4026487-Kinetics,
pubmed-meshheading:4026487-Lidocaine,
pubmed-meshheading:4026487-Male,
pubmed-meshheading:4026487-Middle Aged,
pubmed-meshheading:4026487-Time Factors
|
pubmed:year |
1985
|
pubmed:articleTitle |
Simple method for maintaining serum lidocaine levels in the therapeutic range.
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|